[ad_1]
Three calls received the French emergency service from the family of Cynthia, a 19-year-old girl who died in three days of coronavirus and that when he received help It was late. Death has occurred a early May, in the town of Evry-Courcouronnes. The young woman had co-morbidities and bronchitis and lost his life due to “lung damage” and lack of oxygen, according to the autopsy. The suggestion they made to relatives was: “Give him paracetamol.” The relatives of the victim made a complaint for manslaughter.
On Friday April 30, the young woman began to have difficulty in breathing in addition to other symptoms such as fever and vomiting. From the emergency department, they told relatives that “it was just the start of symptoms” and suggested they give her paracetamol. On Saturday she had the same symptoms and on Sunday the young woman’s situation worsened because vomited blood and had 40 degrees fever. Over the weekend, they contacted emergency services again, who again made the same suggestion. Sunday, the young woman died.
// Ibuprofen would not be risky for patients with COVID-19
The sources of the investigation estimated that the emergency services could “control his breathing and oxygenate him if necessary”. They claimed that although “there was a cry for help, the young woman was not helped “ and that what happened is “unforgivable”. They said that service workers “may be tired, but they cannot do the job halfway.”
From the Center Hospitalier du Sud Ile-de-France to which the emergency medical service belongs, they reported having had a request to record calls from the victim’s family. They confirmed they had sent an ambulance for “emergency care” for the young woman, who ultimately died. An internal investigation will be carried out and the person in charge of the service will have to make a report, according to The Parisian.
The use of paracetamol in patients with coronavirus
At the start of the pandemic and then with the spread of COVID-19, doubts arose about the possible risks of using ibuprofen in infected patients. This has led to investigations into the safety of the use of the nonsteroidal anti-inflammatory drugs. These versions have gained relevance thanks to statements by some European officials and the World Health Organization (WHO) itself. The spokesperson for the body Christian Lindmeier said last year: “Our experts are studying to be able to give future guidance, but in the meantime we recommend using paracetamol Yes not ibuprofen during self-medication ”.
In one of the reviews published by scientific publications, it was pointed out that “the administration of non-steroidal anti-inflammatory drugs was not associated with mortality after 30 days, hospitalization, entered intensive care units (UCI), mechanical ventilation or renal replacement therapy in Danes who tested positive for SARS-CoV-2 ”. In another article, it was stated that “the use of ibuprofen was not associated with worse clinical outcomes, compared to paracetamol or without antipyretics”. The report states that “the use of this type of anti-inflammatory drug before admission is not associated with kidney failure or increased mortality” in patients with coronavirus.
.
[ad_2]
Source link